Trials / Recruiting
RecruitingNCT05248763
Taiwan Cancer Moonshot Project
Taiwan Cancer Moonshot Project: 1. Next-generation Pathway of Taiwan Cancer Precision Medicine (Subjective Aim 1- Taiwan Cancer Moonshot Project); 2. Development of Novel Treatments for Major Diseases (Subproject 5 - Multiomic Big Data-based Intelligent Navigation System for Precision Oncology)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,190 (estimated)
- Sponsor
- Academia Sinica, Taiwan · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to establish multiomic big data under strictly collected clinical samples from tumors, adjacent normal tissue, blood, and clinical data then analyze by using integrated proteomics and genetics platform.
Detailed description
Multiomic integrative analysis is an effective strategy to facilitate the investigation of molecular mechanism, cause, and early intervention of specific diseases. Gastric cancer is specifically chosen for our research target to decrease its incidence and improve survival. To increase precision diagnosis, prognosis and precision therapy, patients from Taiwan are selected as cohort subjects. The aim of this study is to establish multiomic big data under strictly collected clinical samples from tumors, adjacent normal tissue, blood, and clinical data then analyze by using integrated proteomics and genetics platform. Genome, transcriptome, genomic methylation, proteomics, and post-translational modification will be used to construct a map for determine the in-depth carcinogenesis of gastric cancer and strategies for cancer early diagnosis, prevention, and targeted treatments.
Conditions
Timeline
- Start date
- 2022-02-21
- Primary completion
- 2026-12-31
- Completion
- 2035-12-31
- First posted
- 2022-02-21
- Last updated
- 2022-07-20
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05248763. Inclusion in this directory is not an endorsement.